Taiwan FDA orders recall of defective hypertension drug

The Taiwan Food and Drug Administration (FDA) announced Wednesday that it will recall 300,000 Amvlo Film-Coated Tablets 5/160mg that are used to treat high blood pressure after a stability test of the drug yielded low dissolution results, which is likely to affect their efficacy.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)